References
- Grow B, Elgin B, Weintraub A. Bitter Pills (special report). Business Week. December 18, 2006.
- World Health Organization. Trade, Foreign Policy, Diplomacy and Health. Generic drugs, http://www.who.int/trade/glossary/story034/en/. Accessed August 15, 2008.
- The True Costs Web site, http://www.thetruecosts.org. Accessed August 15, 2008.
- Center for Medicine in the Public Interest, http://www.cmpi.org. Accessed August 15, 2008.
- Underwriters Laboratories. Anti-counterfeiting operations. http://www.ul.com/ace/. Accessed August 15, 2008.
- World Health Organization. Counterfeit medicines. WHO Fact sheet No. 275. Revised November 14, 2006. http://www.who.int/mediacentre/factsheets/fs275/en/. Accessed August 15, 2008.
- US Food and Drug Administration. FDA warns consumers about counterfeit drugs from multiple internet sellers.” May 1, 2007. http://www.fda.gov/bbs/topics/NEWS/2007/NEW01623.html. Accessed August 15, 2008.
- US Food and Drug Administration. FDA Counterfeit Drug Task Force Report. June 8, 2006. http://www.fda.gov/oc/initiatives/counterfeit/report6_06.html. Accessed August 15, 2008.
- Morris J, Stevens P. Counterfeit medicines in less developed countries: Problems and solutions. International Policy Network. London, UK. 2006. http://www.fightingdiseases.org/pflf/ipn_counterfeit.pdf. Accessed August 15, 2008.
- Institute of Medicine of the National Academies. Preventing medication errors: quality chasm series. July 20, 2006. http://www.iom.edu/CMS/3809/22526/35939.aspx. Accessed August 15, 2008.
- The Institute for Safe Medication Practices. Electronic prescribing can reduce medication errors. 2000. Accessed August 15, 2008.
- US Food and Drug Administration. Federal Register. Vol 68. No 50. Page 12499–12534. March 14, 2003. http://www.fda.gov/OHRMS/DOCKETS/98fr/03-5205.html. Accessed August 15, 2008.
- Rothschild JM, Federico FA, Gandhi TK, Kaushal R, Williams DH, Bates DW. Analysis of medication-related malpractice claims: causes, preventability, and costs. Arch Intern Med. 2002; 162(21): 2414–2420.
- Glabman M. The top ten malpractice claims [and how to minimize them]. Hospitals and Health Networks. September 9, 2004. http://www.hhnmag.com/hhnmag_app/hospitalconnect/search/article.jsp?dcrpath=HHNMAG/PubsNewsArticle/data/0409HHN_FEA_Malpractice&domain=HHNMAG. Accessed August 15, 2008.
- US Food and Drug Administration. Federal Register. Vol 69. No 38. Page 9119–9171. February 26, 2004. http://www.fda.gov/OHRMS/DOCKETS/98fr/04-4249.htm. Accessed August 15, 2008.
- Koppel R, Wetterneck T, Telles JL, Karsh BT. Workarounds to barcode medication administration systems: their occurrences, causes, and threats to patient safety. J Am Med Inform Assoc. 2008; 15(4): 408–123.
- Scalet SD. Radio-frequency ID (RFID) as an answer to pharmaceutical drug counterfeiting: five myths about how radio-frequency ID (RFID) technology will stop counterfeit drugs. CIO Magazine. May 11, 2007.
- Congressional testimony. Oral statement of James Christian, Vice President and Head of Global Corporate Security, Novartis International AG, before the Subcommittee on Commerce, Trade, and Consumer Protection House Energy and Commerce Committee, June 15, 2005. US House, 108th Congress, Hearing 155.http://energycommerce.house.gov/reparchives/108/Hearings/06152005hearing1551/Christian.pdf. Accessed August 15, 2008.
- Eban K. Dangerous Doses. Harcourt: New York, NY; 2006.
- Congressional Record. Congressman Steve J. Israel. The Introduction Of “Tim Fagan's Law.” US House, 109th Congress, Extensions of Remarks, May 12, 2005. http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?dbname=2005_record&page=E950&position=all. Accessed August 18, 2008.
- US Food and Drug Administration. Center for Drug Evaluation and Research. FDA guidance for industry, immediate release solid oral dosage forms, scale-up and postapproval changes: chemistry, manufacturing, and controls, in vitro dissolution testing, and in vivo bio-equivalence documentation. November 1995. Available at http://www.fda.gov/CDER/guidance/cmc5.pdf. Accessed August 15, 2008.
- Rodionova OY, Houmoller LP, Pomerantsev AL, Geladi P, Burger J, Dorofeyev VL, Arzamastsev AP. NIR spectrometry for counterfeit drug detection. Analytica Chimica Acta 2005; 549(1–2): 151.
- Baer I, Gumy R, Margot P. NIR analysis of cellulose and lactose—Application to ecstasy tablet analysis. Forensic Science International 2007; 167(2–3): 234–241.
- Vredenbregt MJ, Blok-Tip L, Hoogerbrugge R, Barenda DM, de Kaste D. Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopy. J Pharm Biomed Anal. 2006; 40(4): 840–849.
- Rijksinstituut voor Volksgezondheld en Milieu (RIVM). Venhuis BJ, Barends DM, Zwaagstra ME, de Kaste D. Recent developments in counterfeits and imitations of Viagra, Cialis and Levitra: A 2005–2006 update. RIVM Report 370030001/2007. November 13, 2007.
- Workman J, Jr. An introduction to near infrared spectroscopy. Spectroscopy Now. September 12,2005. http://www.spectroscopynow.com/coi/cda/detail.cda?id=1881&type=EducationFeature&chId=2&page=l. Accessed August 18, 2008.
- Scafi SH, Pasquini C. Identification of counterfeit drugs using near-infrared spectroscopy. Analyst. 2001; 126(12): 2218–2224.
- Tabasi A, Polli JE, Hoag SW. Application of Near Infrared Spectroscopy to Differentiate Counterfeit and Authentic Drug Products. The AAPS Journal. http://www.aapsj.org/abstracts/AM_2005/AAPS2005-002603.pdf. Accessed August 18, 2008.
- Daily Times (Pakistan). Man allegedly used goat urine to make pirate perfume. October 7, 2002. http://www.dailytimes.com.pk/default.asp?page=story_7-10-2002_pg9_6. Accessed August 18, 2008.
- Ottewell D, Keegan M. On sale: perfume laced with urine. Manchester Evening News. October 13, 2006. http://www.manchestereveningnews.co.uk/news/s/225/225433_on_sale_perfume_laced_with_urine.html. Accessed August 18, 2008.
- Lister D, O'Neill S. IRA plc turns from terror into biggest crime gang in Europe. The Times. London, UK. February 25, 2005.
- Faber P. “RFID strategy—pharmaceutical e-pedigree—biggest supply chain topic of 2008,” Industry Week. January 21, 2008.
- US Food and Drug Administration. US FDA Counterfeit Alert Network. http://www.fda.gov/oc/initiatives/counterfeit/network.html. Accessed August 18, 2008.
- The National Association of Boards of Pharmacy, http://www.nabp.net. Accessed August 18, 2008.